Kaohsiung, Taiwan

Yen-Shian Wu

This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yen-Shian Wu. Retrieved from https://idiyas.com/inventor/yen-shian-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yen-Shian Wu: Innovator in Hepatitis C Treatment

Introduction

Yen-Shian Wu is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating viral infections.

Latest Patents

Yen-Shian Wu holds a patent for "Imidazolidinone and imidazolidinethione derivatives." This patent includes imidazolidinone and imidazolinethione compounds of a specific formula, wherein various components are defined. The patent also discloses a method for treating hepatitis C virus infection using these innovative compounds. He has 1 patent to his name.

Career Highlights

Wu is affiliated with the National Health Research Institutes, where he conducts research focused on developing therapeutic solutions for viral infections. His work has the potential to impact public health significantly.

Collaborations

Yen-Shian Wu has collaborated with notable colleagues, including Jyh-Haur Chern and Tsu-An Hsu, who contribute to his research endeavors.

Conclusion

Yen-Shian Wu's innovative work in the field of medicinal chemistry highlights his commitment to advancing treatments for hepatitis C. His contributions are vital in the ongoing fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…